In the 2nd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Can you describe some therapeutic areas where specialized pro-resolving mediators are currently being investigated for clinical use?” Dr. Serhan discusses the most current therapeutic research assessing SPM efficacy, including pulmonary, cardiometabolic, vascular, joint and cognitive health, as well as pain and wound healing.
Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital and Professor of Anesthesia at Harvard Medical School.
From the 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2017 in Puerto Vallarta, Mexico
